
Maximizing Diagnostic Yield When It’s Needed Most – Ultrarapid Genome Sequencing in Newborns
Ultrarapid genome sequencing is steadily gaining adoption as a first-tier diagnostic test in the neonatal population. Join Madhuri Hegde, PhD, FACMG, in examining how PerkinElmer Genomics leverages dried blood spot (DBS) sampling to provide meaningful results in only five days.